Health Affairs July 30, 2020
As the coronavirus disease 2019 (COVID-19) pandemic continues to claim lives and reduce global economic output, scientists are working on developing a widely accessible vaccine. However, policy makers and economists have expressed concern that, lacking appropriate incentives and coordination, private markets may fail to adequately incentivize vaccine investments, particularly at the speed or scale required to mitigate this pandemic. A new study, released as a Fast Track Ahead Of Print article by Health Affairs, proposes a “pull” program that incentivizes late-stage development for COVID-19 vaccines by awarding advance purchase commitments to bidding firms. The authors’ model was created by collecting and analyzing data from several sources to estimate demand and costs in the market for a COVID-19 vaccine and forecasting...